Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison

Purpose: Eye-dedicated proton therapy (PT) facilities are used to treat malignant intraocular lesions, especially uveal melanoma (UM). The first commercial ocular PT beamline from Varian was installed in the Netherlands. In this work, the conceptual design of the new eyeline is presented. In addition, a comprehensive comparison against five PT centers with dedicated ocular beamlines is performed, and the clinical impact of the identified differences is analyzed. Material/Methods: The HollandPTC eyeline was characterized. Four centers in Europe and one in the United States joined the study. All... Mehr ...

Verfasser: E.M.J. (Emmanuelle) Fleury
P. (Petra) Trnková
Kees Spruijt
Joël Herault
Franciska Lebbink
Jens Heufelder
Jan Hrbacek
Tomasz Horwacik
Tomasz Kajdrowicz
Andrea Denker
Anaïs Gerard
Petter Hofverberg
Maria Mamalui
Roelf Slopsema
JP (Jean-Philippe) Pignol
M.S. (Mischa) Hoogeman
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-26725950
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://repub.eur.nl/pub/135737